PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Veterinary Physiology and Zürich Center for Integrative Human Physiology, University of Zürich, Zürich, Switzerland.\', \'Department of Fundamental Neurobiology, Krembil Research Institute, University Health Network, University of Toronto, Toronto, Canada; Division of Neurosurgery, Department of Surgery, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, Canada; Group of Brain Vasculature and Neurovascular Unit, Division of Neurosurgery, Department of Clinical Neurosciences, University Hospital Geneva, Geneva, Switzerland; Group of CNS Angiogenesis and Neurovascular Link, Institute for Regenerative Medicine, Neuroscience Center Zürich, University Hospital Zürich, Zürich, Switzerland; Division of Neurosurgery, University Hospital Zürich, Zürich, Switzerland.\', \'Institute of Veterinary Physiology and Zürich Center for Integrative Human Physiology, University of Zürich, Zürich, Switzerland. Electronic address: jvogel@vetphys.uzh.ch.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1471-4914(20)30267-710.1016/j.molmed.2020.10.005
?:doi
?:hasPublicationType
?:journal
  • Trends in molecular medicine
is ?:pmid of
?:pmid
?:pmid
  • 33129692
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 4.876
?:rankingScore_hIndex
  • 153
is ?:relation_isRelatedTo_publication of
?:title
  • CGRP Receptor Antagonism in COVID-19: Potential Cardiopulmonary Adverse Effects.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all